Heart Disease | Page 66 of 95

Teen girls make better health choices with intervention program

For two consecutive years, researchers examined measures of cardiovascular fitness and self-esteem in sophomore girls attending Trenton Central High School and found students are making better health choices with an intervention program. Low Density Lipoprotein levels — the unhealthy cholesterol — also decreased significantly. WHF Teen Esteem is a gender-specific approach to teen girls’ health and wellness and is meant to be a replacement for traditional gymnastics and health classes.

Teen girls make better health choices with intervention program

ACTOS (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT

Researchers today presented data showing that ACTOS (pioglitazone HCl) halted the progression of atherosclerosis as measured by carotid intima-media thickness (CIMT) in patients with type 2 diabetes. Results from the clinical trial, CHICAGO (Carotid intima-media thickness in Atherosclerosis using pioglitazone), are part of a late-breaker presentation at the American Heart Association’s Scientific Sessions 2006, coincidentally being held in Chicago, and coincide with an early online issue of the Journal of the American Medical Association.

Heart Disease :: Specific strategic plans ensure timely emergency care for heart attack patients

Hospitals that provide the most rapid emergency angioplasty have specific strategies to expedite the care of patients with heart attacks, researchers at Yale School of Medicine report in the November 13 New England Journal of Medicine.

MRI :: Effectiveness of noninvasive whole-heart MRI

Researchers have long sought to find a reliable way to see inside the human heart without having to insert tubes, inject dyes or expose patients to potentially dangerous radiation. One possible solution is the whole-heart MRI, which provides 3-D images of the heart and its blood vessels without the risk of an invasive procedure.

Heart Disease :: Novel anticoagulant-antidote combination shown safe in humans

A new combination of a potent anticoagulant and an antidote that stops its action, has proved to be safe in its first clinical trial in humans, according to the team conducting the trial.

Dementia :: Higher level of certain fatty acid associated with lower dementia risk

Individuals who have higher levels of a fatty acid known as docosahexaenoic acid in their blood may have a significantly lower risk of developing dementia and Alzheimer’s disease, according to a report in the November issue of Archives of Neurology, one of the JAMA/Archives journals.

Stroke :: Younger stroke survivors have less access to medical care, medications

Stroke survivors less than 65 years old report having more difficulty accessing physicians and affording medications than stroke survivors older than 65, according to an article posted online today that will appear in the January 2007 print issue of Archives of Neurology, one of the JAMA/Archives journals.

Heart Disease :: RNA contribute mightily to heart problem

Tiny bits of RNA — a chemical cousin of DNA — play a large role in causing enlargement of the heart, which is a major risk factor for heart failure and sudden death, researchers at UT Southwestern Medical Center have discovered.

Depression :: Depression, not antidepressants, increases heart failure risk

People who are depressed have an increased risk of dying from heart failure, and a new study by Duke University Medical Center researchers may help explain why.